Back
Illumina 10K Form
Sell
42
ILMN
Illumina
Last Price:
140.12
Seasonality Move:
16.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | ILMN/Illumina Quarterly |
| 2024-02-16 | 10K | ILMN/Illumina Annual |
| 2023-11-13 | 10Q | ILMN/Illumina Quarterly |
| 2023-08-10 | 10Q | ILMN/Illumina Quarterly |
| 2023-05-05 | 10Q | ILMN/Illumina Quarterly |
| 2023-02-17 | 10K | ILMN/Illumina Annual |
Receive ILMN News And Ratings
See the #1 stock for the next 7 days that we like better than ILMN
ILMN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.5B |
|---|---|
| Cash Flow: | $284M |
| Price / Cash Flow: | 40.81 |
| Annual Sales: | $13.45 |
| Price / Book: | 10.46 |
Profitability
| EPS (TTM): | -9.96000 |
|---|---|
| Net Income (TTM): | $-1.58B |
| Gross Margin: | $2.74B |
| Return on Equity: | -37.83% |
| Return on Assets: | -18.69% |
Illumina Earnings Forecast
Key Illumina Financial Ratios
- The Gross Profit Margin over the past 25 years for ILMN is 60.92%.
- The Selling, General & Administrative Expenses for ILMN have been equal to 35.79% of Gross Profit Margin.
- The Research & Development expenses have been 30.06% of Revenue.
- The Interest Expense is -6.63% of Operating Income.
- The Net Earning history of ILMN is -25.78% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 16 years.
Illumina Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | ILMN |
| CUSIP: | 452327 |
| Website: | illumina.com |
Debt
| Debt-to-Equity Ratio: | 0.94 |
|---|---|
| Current Ratio: | 2.43 |
| Quick Ratio: | 1.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 31.5 |